BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23782484)

  • 1. The challenges of success: adolescents with perinatal HIV infection.
    Mofenson LM; Cotton MF
    J Int AIDS Soc; 2013 Jun; 16(1):18650. PubMed ID: 23782484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection.
    Hazra R; Siberry GK; Mofenson LM
    Annu Rev Med; 2010; 61():169-85. PubMed ID: 19622036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.
    Sohn AH; Hazra R
    J Int AIDS Soc; 2013 Jun; 16(1):18555. PubMed ID: 23782474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative Comparison of Barriers to Antiretroviral Medication Adherence Among Perinatally and Behaviorally HIV-Infected Youth.
    Fields EL; Bogart LM; Thurston IB; Hu CH; Skeer MR; Safren SA; Mimiaga MJ
    Qual Health Res; 2017 Jul; 27(8):1177-1189. PubMed ID: 28682737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescents with perinatally acquired HIV: emerging behavioral and health needs for long-term survivors.
    Koenig LJ; Nesheim S; Abramowitz S
    Curr Opin Obstet Gynecol; 2011 Oct; 23(5):321-7. PubMed ID: 21836510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children.
    Vreeman RC; Scanlon ML; McHenry MS; Nyandiko WM
    J Int AIDS Soc; 2015; 18(Suppl 6):20258. PubMed ID: 26639114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents.
    Agwu AL; Fairlie L
    J Int AIDS Soc; 2013 Jun; 16(1):18579. PubMed ID: 23782477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The needs for HIV treatment and care of children, adolescents, pregnant women and older people in low-income and middle-income countries.
    Kenny J; Mulenga V; Hoskins S; Scholten F; Gibb DM
    AIDS; 2012 Dec; 26 Suppl 2():S105-16. PubMed ID: 23303433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group].
    Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R
    Sante; 1997; 7(2):115-25. PubMed ID: 9273118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.
    Mofenson LM; Munderi P
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):200-15. PubMed ID: 12045684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliminating vertically-transmitted HIV/AIDS while improving access to treatment and care for women, children and adolescents in Jamaica.
    Christie CD; Pierre RB
    West Indian Med J; 2012 Jul; 61(4):396-404. PubMed ID: 23240475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing psychological vulnerabilities among behaviourally and perinatally HIV infected adolescents in South Africa - implications for targeted health service provision.
    Sherr L; Cluver LD; Toska E; He E
    AIDS Care; 2018 Jun; 30(sup2):92-101. PubMed ID: 29848010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHAMP+ Thailand: Pilot Randomized Control Trial of a Family-Based Psychosocial Intervention for Perinatally HIV-Infected Early Adolescents.
    Nestadt DF; Saisaengjan C; McKay MM; Bunupuradah T; Pardo G; Lakhonpon S; Gopalan P; Leu CS; Petdachai W; Kosalaraksa P; Srirompotong U; Ananworanich J; Mellins CA
    AIDS Patient Care STDS; 2019 May; 33(5):227-236. PubMed ID: 31067121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the use of antiretroviral agents in pediatric HIV infection--HRSA. Request for comments.
    Fed Regist; 1997 Sep; 62(189):51115-6. PubMed ID: 10175219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing antiretroviral therapy in adolescents with perinatally acquired HIV-1 infection.
    Foster C; Fidler S
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1403-16. PubMed ID: 21133665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth.
    Mellins CA; Elkington KS; Leu CS; Santamaria EK; Dolezal C; Wiznia A; Bamji M; Mckay MM; Abrams EJ
    AIDS Care; 2012; 24(8):953-62. PubMed ID: 22519762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.